VERA
Vera Therapeutics Inc
32.50$
-2.4%
vs. previous close
Closing price · As of: Sep 25, 2026
Statements
Cash Flow
All figures per share in USD.
Tick rows to compare them in a chart (up to 4)
| Line item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| -3.01 | -9.39 | -1.76 | -2.54 | -2.16 | -2.43 | -3.75 | |
| 0.15 | 0.07 | 0.01 | -0.03 | -0.10 | 0.00 | 0.01 | |
| 0.08 | 0.09 | 0.22 | 0.33 | 0.27 | 0.38 | 0.59 | |
| 0.16 | 4.91 | -0.05 | 0.33 | – | – | – | |
| 0.15 | 0.03 | 0.26 | 0.25 | -0.14 | 0.05 | 0.36 | |
| 0.04 | 0.03 | 0.00 | 0.00 | 0.00 | 0.02 | 0.01 | |
| -0.04 | -0.01 | -0.31 | -2.66 | -0.92 | -7.68 | 3.02 | |
| – | – | 3.64 | 0.08 | 0.00 | 0.00 | 0.00 | |
| -0.05 | 1.48 | 0.37 | 0.75 | 0.58 | 0.00 | 0.36 | |
| -0.04 | 23.00 | 4.01 | 3.84 | 3.13 | 10.97 | 4.81 | |
| -3.08 | 13.60 | 1.93 | -1.36 | 0.05 | 0.85 | 4.08 | |
| -3.04 | -9.41 | -1.76 | -2.55 | -2.16 | -2.45 | -3.76 |
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.